Tobramycin and sisomicin showed a tendency to inhibit SARS-CoV-2 replication in human induced pluripotent stem cell (hiPSC)-derived lung organoids, though the effect did not reach statistical significance.
← all excerpts
Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics.
1
—
—